Last updated on November 2017

A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo-Controlled study to evaluate the Long-Term safety and the efficacy of Fasinumab in patients with pain due to osteoarthritis of the knee of hip.


Brief description of study

A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo-Controlled study to evaluate the Long-Term safety and the efficacy of Fasinumab in patients with pain due to osteoarthritis of the knee of hip.

Detailed Study Description

Participation in this research study of an investigational drug could last up to 18 months and include approximately 17 clinic visits. Reimbursement may be provided to qualified participants for time and travel.

Clinical Study Identifier: TX10501

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Recruitment

Metroplex Clinical Research Center
Dallas, TX USA
  Connect »